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Abstract. 
 
In 
 
Saccharomyces cerevisiae
 
, transfer of
N-linked oligosaccharides is immediately followed by 
trimming of ER-localized glycosidases. We analyzed 
the influence of specific oligosaccharide structures for 
degradation of misfolded carboxypeptidase Y (CPY). 
By studying the trimming reactions in vivo, we found 
 
that removal of the terminal 
 
a
 
1,2 glucose and the first 
 
a
 
1,3 glucose by glucosidase I and glucosidase II respec-
tively, occurred rapidly, whereas mannose cleavage by 
mannosidase I was slow. Transport and maturation of 
correctly folded CPY was not dependent on oligosac-
charide structure. However, degradation of misfolded 
CPY was dependent on specific trimming steps. Degra-
dation of misfolded CPY with N-linked oligosaccha-
rides containing glucose residues was less efficient com-
pared with misfolded CPY bearing the correctly 
 
trimmed Man
 
8
 
GlcNAc
 
2
 
 oligosaccharide. Reduced
rate of degradation was mainly observed for mis-
folded CPY bearing Man
 
6
 
GlcNAc
 
2
 
, Man
 
7
 
GlcNAc
 
2
 
and Man
 
9
 
GlcNAc
 
2
 
 oligosaccharides, whereas 
Man
 
8
 
GlcNAc
 
2
 
 and, to a lesser extent, Man
 
5
 
GlcNAc
 
2
 
 
oligosaccharides supported degradation. These results 
suggest a role for the Man
 
8
 
GlcNAc
 
2
 
 oligosaccharide in 
the degradation process. They may indicate the pres-
ence of a Man
 
8
 
GlcNAc
 
2
 
-binding lectin involved in tar-
geting of misfolded glycoproteins to degradation in 
 
S
 
.
 
 
cerevisiae
 
.
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I
 
n
 
 
 
Saccharomyces cerevisiae
 
, as in other eukaryotes, the
synthesis of asparagine-linked glycoproteins takes
place in the ER. After transfer to protein, the N-linked
oligosaccharide (NLO),
 
1
 
 while present in the ER, is sub-
ject to trimming reactions (see Fig. 1) involving glucosi-
dase I, glucosidase II, and mannosidase I (Herscovics and
Orlean, 1993; Moremen et al., 1994; Roth, 1995). In higher
eukaryotes, a specific role of the trimming intermediate
Glc
 
1
 
Man
 
9
 
GlcNAc
 
2
 
 oligosaccharide in the ER quality con-
trol process has been proposed (Helenius et al., 1997). An
incorrectly folded glycoprotein bearing such an oligosac-
charide structure is bound by specific ER resident proteins
and retained in a folding competent environment. Cor-
rectly folded glycoproteins can exit the ER, enter the
Golgi apparatus, and are delivered to their final destina-
tion. However, improperly folded glycoproteins are re-
tained in the ER and are eventually degraded. In many
cases, degradation occurs via the ubiquitin–proteasome
pathway that requires their exit from the ER lumen to the
cytosol as shown both in higher eukaryotic cells and in
yeast (Jentsch and Schlenker, 1995; Bonifacino, 1996; Ko-
pito, 1997; Sommer and Wolf, 1997; Varshavsky, 1997).
For the export to the cytosol, constituents of the ER trans-
locon play an important role (Pilon et al., 1997; Plemper
et al., 1997). Additionally, ER proteins such as the chaper-
one Kar2p (Plemper et al., 1997), as well as the ubiquitin-
conjugating proteins Ubc6p and Ubc7p, are thought to be
involved in this process (Biederer et al., 1996; Hiller et al.,
1996). In 
 
Saccharomyces cerevisiae
 
, the proteolysis of non-
glycosylated 
 
a
 
-factor is ATP and cytosol-dependent (Mc-
Cracken and Brodsky, 1996) and also mutated and there-
fore misfolded carboxypeptidase Y (
 
prc1-1
 
, CPY*; Wolf
and Fink, 1975; Finger et al., 1993) has been shown to en-
ter the ubiquitin–proteasome pathway (Hiller et al., 1996).
The degradation of the misfolded protein appears to be
glycosylation dependent, since nonglycosylated CPY* re-
mains stable in the ER (Knop et al., 1996). Moreover, the
degradation also appears to be mannosidase I–dependent
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(Knop et al., 1996). Despite this, the molecular signals re-
quired for the initiation of ER glycoprotein degradation
are not known.
We investigated the possible role of specific oligosac-
charide structures in degradation of CPY* by genetic tai-
loring of the protein-bound oligosaccharide structure. We
found that the Man
 
8
 
GlcNAc
 
2
 
 structure as the final product
of the trimming reaction in the ER in yeast (Byrd et al.,
1982) was mandatory for efficient degradation. Our results
suggest that the ER 
 
a
 
1,2-mannosidase represents a key
enzyme for timing the onset of degradation. The period re-
quired for complete oligosaccharide trimming appears to
be the time frame for glycoproteins to fold correctly.
 
Materials and Methods
 
Materials
 
Strains used are detailed in Table I. Wild-type denotes a strain with both
normal biosynthesis of lipid-linked oligosaccharides and trimming of pro-
tein-bound oligosaccharides but harboring the 
 
prc1-1
 
 mutation. Oligonu-
cleotides (Microsynth, Balgach, Switzerland) used for gene deletion and
screenings are listed in Table II. The integrative plasmid 
 
pRS306-prc1-1
 
containing the mutated CPY gene was provided by Dr. D.H. Wolf (Uni-
versity of Stuttgart, Germany). The antiserum against yeast hexokinase
was provided by Dr. S. Schröder (Biozentrum, University of Basel, Swit-
zerland).
 
Yeast Manipulations
 
Standard protocols were followed for growth of yeast, mating, sporula-
tion, and ascus dissection (Guthrie and Fink, 1991). If not otherwise
stated, the cells were grown at 30
 
8
 
C in either YPD medium (2% Bacto-
Peptone, 1% Yeast extract [both from Difco Laboratories, Detroit, MI],
2% glucose) or for metabolic labeling experiments in MV medium (0.67%
Yeast nitrogen base [Difco Laboratories], 2% glucose and the appropriate
supplements).
 
Construction of Strains
 
Disruption of the MNS1 Locus. 
 
The 
 
MNS1 
 
locus ORF YJR131w (these
data are available from GenBank/EMBL/DDBJ under accession number
Z49631; Grondin and Herscovics, 1992) was inactivated by replacing a
major part of the locus with the KanMX cassette (Wach et al., 1994). The
 
Table I. Yeast Strains Used in This Study
 
Strain Genotype Reference
 
SS328 MAT
 
a
 
 
 
ade2-101 ura3-52 his3
 
D
 
200 lys2-801
 
Vijayraghavan et al. (1989)
YG268 MAT
 
a
 
 
 
ade2-101 ura3-52 his3
 
D
 
200 lys2-801
 
 
 
D
 
alg3::HIS3
 
Aebi et al. (1996)
YG414 MAT
 
a
 
 
 
ade2-101 ura3-52 his3
 
D
 
200 lys2-801
 
 
 
D
 
alg9
 
::KanMX Burda et al. (1996)
YG427 MAT
 
a
 
 
 
ade2-101 ura3-52 his3
 
D
 
200 lys2-801
 
 
 
D
 
gls2
 
::KanMX Jakob et al. (1998)
YG590 MAT
 
a
 
 
 
ade2-101 ura3-52 his3
 
D
 
200 lys2-801
 
 
 
D
 
gls2
 
::KanMX
 
 
 
D
 
alg6::HIS3
 
Jakob et al. (1998)
YG424 MAT
 
a
 
 
 
ade2-101 ura3-52 his3
 
D
 
200 lys2-801
 
 
 
D
 
gls2
 
::KanMX
 
 
 
D
 
alg8::HIS3
 
Jakob et al. (1998)
YG491 MAT
 
a
 
 
 
ade2-101 ura3-52 his3
 
D
 
200 lys2-801
 
 
 
D
 
gls2
 
::KanMX
 
 
 
D
 
alg10::KanMX
 
Jakob et al. (1998)
YG746 MAT
 
a
 
 
 
ade2-101 ura3-52 his3
 
D
 
200
 
 
 
tyr1 
 
D
 
mns1
 
::KanMX This study
YG618 MAT
 
a 
 
ade2-101 ura3-52 his3
 
D
 
200 lys2-801 prc1-1
 
This study
YG619 MAT
 
a
 
 
 
ade2-101 ura3-52 his3
 
D
 
200
 
 
 
lys2-801 
 
D
 
gls2
 
::KanMX 
 
prc1-1
 
This study
YG620 MAT
 
a
 
 
 
ade2-101 ura3-52 his3
 
D
 
200
 
 
 
lys2-801
 
 
 
D
 
alg6::HIS3 prc1-1
 
This study
YG623 MAT
 
a
 
 
 
ade2-101 ura3-52 his3
 
D
 
200
 
 
 
lys2-801
 
 
 
D
 
gls2
 
::KanMX 
 
D
 
alg6::HIS3 prc1-1
 
This study
YG624 MAT
 
a
 
 
 
ade2-101 ura3-52 his3
 
D
 
200
 
 
 
lys2-801
 
 
 
D
 
gls2
 
::KanMX 
 
D
 
alg8::HIS3 prc1-1
 
This study
YG696 MAT
 
a
 
 
 
ade2-101 ura3-52 his3
 
D
 
200
 
 
 
lys2-801
 
 
 
D
 
gls2
 
::KanMX 
 
D
 
alg10
 
::KanMX
 
 prc1-1
 
This study
YG796 MAT
 
a
 
 
 
ade2-101 ura3-52 lys2-801
 
 
 
his3
 
D
 
200
 
 
 
D
 
alg9
 
::KanMX prc1-1 This study
YG797 MATa ade2-101 ura3-52 lys2-801 his3D200 Dalg3::HIS3 prc1-1 This study
YG807 MATa ade2-101 ura3-52 lys2-801 his3D200 Dalg12::KanMX prc1-1 This study
YG777 MATa ade2-101 ura3-52 lys2-801 his3D200 Dmns1::KanMX prc1-1 This study
YG556 MATa ura3-52 his3D200 lys2-801 leu2 sec18-50 This study
YG557 MATa ade2-101 ura3-52 his3D200 lys2-801 leu2 Dgls2::KanMX sec18-50 This study
YG821 MATa ade2-101 ura3-52 his3D200 lys2-801 prc1-1 YEp352 This study
YG822 MATa ade2-101 ura3-52 lys2-801 his3D200 Dalg9::KanMX prc1-1 pALG9 This study
YG823 MATa ade2-101 ura3-52 lys2-801 his3D200 Dalg3::HIS3 prc1-1 pALG3 This study
YG824 MATa ade2-101 ura3-52 lys2-801 his3D200 Dalg12::KanMX prc1-1 pALG12 This study
Table II. PCR Primers
Primer Sequence (59®39)*
Knockout primers
MNS1forKan aaacattgaaaaaggattctatgaagaactctgtcggtattcgatgaattcgagctc
MNS1revKan ccactatatagcacactaacctacaacgaccaacctgtggcgtacgctgcaggtcgac
MNS1-68u tgccaagaaacgaaagac
MNS11431L cggataataaaccaccta
ALG12forKan aaaagagttgaataaagccattaaacaacgattcagttgacatcgatgaattcgagctc
ALG12revKan gctcgctatatattttattggaattgacgttagctattatcacgtacgctgcaggtcgac
ALG12for caaccttttaccagccgg
KanMXu gtattgatgttggacgag
Primer for prc1-1 screen
CPY462u ggatccggtcatcctttg
CPY885L ctgagtcaatgggtcagt
*Bold face letters represent locus-specific sequence.Jakob et al. Glycoprotein Degradation in Yeast 1225
sequence of the kanamycin resistance gene was amplified by PCR by us-
ing the template pFA6a-KanMX4 plasmid (Wach et al., 1994) and the
primers MNS1forKan and MNS1revKan (Table II). The resulting DNA
was transformed into strain SS328 and the cells were selected on G418
plates (200 mg/ml). Transformants were analyzed for correct integration
by whole cell PCR (Sathe et al., 1991) using KanMXu and the MNS1-spe-
cific MNS1-68u and MNS1 1 431L primers.
Disruption of the ALG12 Locus. The  ALG12 locus ORF YNR030w
(these data are available from GenBank/EMBL/DDBJ under accession
number Z71645; Lussier et al., 1997) was inactivated by the same proce-
dure using the primers ALG12forKan and ALG12revKan for amplifying
the KanMX cassette and KanMXu and ALG12for primers for verifying
the correct gene deletion (Table II).
Replacement of the PRC1 Locus with prc1-1. The BglII-linearized plas-
mid pRS306-prc1-1 (Knop et al., 1996) containing the mutated form
(G255R) of CPY (Wolf and Fink, 1975) was integrated into the PRC1 lo-
cus of various yeast strains, resulting in a duplication of the PRC1 locus.
Strains in which an excision of the duplication by homologous recombina-
tion had occurred were selected on 5-FOA plates and the resulting colo-
nies screened by PCR for the prc1-1 locus. A fragment of the PRC1 locus
was amplified by PCR using the primers CPY462u and CPY855L (Table
II) giving raise to a product of 423 bp. Due to the prc1-1 mutation, a BstXI
restriction site is destroyed. Therefore, strains containing solely the prc1-1
locus were identified by the resistance of the PCR fragment towards
BstXI digestion. Western blot analysis confirmed that they only expressed
mutant CPY*.
Metabolic Labeling and Immunoprecipitations
Stationary grown cells from a YPD overnight culture were inoculated in
minimal medium and cultivated to an OD546nm of 1.0. The cells were har-
vested by centrifugation, washed in minimal medium containing 0.1% glu-
cose and then incubated in the same medium at 308C for at least 3 h. For
pulse–chase experiments, 2 3 107 cells per time point were labeled by the
addition of 50 mCi [35S]methionine (Tran35S-label, 10 mCi/ml; ICN Phar-
maceuticals) for 10 min and then chased with a 100-fold excess of nonra-
dioactive methionine. The chase was terminated by the addition of NaN3
(50 mM final concentration) and immediate freezing in liquid nitrogen.
Protein extractions, immunoprecipitation, and SDS-PAGE were per-
formed as described (Franzusoff et al., 1991; te Heesen et al., 1992). The
dried gels were exposed and analyzed using a PhosphoImager. The kinet-
ics of CPY* degradation were calculated by setting the counts of time
point zero as 100%. For the studies of the transport kinetics of CPY in the
strains with and without Mns1p, the cells were labeled for only 5 min at
268C. The chase, protein extraction, and immunoprecipitation were per-
formed as described above.
Assay for Degradation of CPY* by Western Analysis
Yeast strains were grown at 308C in YPD or minimal medium containing
the appropriate supplements into stationary phase. 3 3 108 cells were har-
vested and broken with glass beads in 50 mM Tris-HCl, pH 7.5, 1% SDS,
2 mM PMSF (Franzusoff et al., 1991; te Heesen et al., 1992). Protein ex-
tract equivalent to 7 3 106 cells was subjected to reducing SDS-PAGE,
transferred to nitrocellulose membranes, and probed with specific anti-
bodies. Binding was visualized by chemiluminescence (SuperSignal UL-
TRA; Pierce Chemical Co., Rockford, IL). The x-ray films were scanned
and the intensity of the protein bands was determined. The antibody con-
jugates on the nitrocellulose membranes were stripped by treatment in
62.5 mM Tris-HCl, pH 6.7, 2% SDS, 100 mM b-mercaptoethanol at 658C
for 45 min, and the membranes were reprobed with another antibody. As
an additional control for equal protein concentrations, protein contents
were determined using the method of Sailer and Weissmann (1991).
Analysis of Lipid-linked and
Protein-linked Oligosaccharides
The analysis of lipid- and protein-linked oligosaccharides has been de-
scribed (Cacan et al., 1993; Zufferey et al., 1995; Jakob et al., 1998). For
pulse–chase labeling of the oligosaccharides, typically 3 3 109 cells of a
logarithmically growing culture were pelleted, washed with YP0.1D (2%
Yeast extract, 1% Bactopeptone, 0.1% glucose), and resuspended in 450 ml
YP0.1D containing 400 mCi 2-[3H]mannose (30 Ci/mmol; ICN Pharma-
ceuticals). The oligosaccharides were labeled for 1 min at 268C and the ra-
dioactivity was chased by adding nonradioactive (6)D-mannose (111 mM
final concentration). At the given time points, 5 3 108 cells were removed,
placed in 1 ml of CM 3:2 (chloroform/methanol 3:2 vol/vol) and mixed by
vortexing. Extraction, work-up and analysis of lipid-linked oligosaccha-
rides (LLO) and NLO was as described above. For detailed verification of
oligosaccharide structure, endo H–released NLO were further digested
with a1,2-specific mannosidase from Aspergillus saitoi (15 mU; Oxford
Glycosystems, Abingdon, UK) in the supplied buffer. After the digest the
NLO were separated by HPLC (see above).
Results
Trimming of Protein-bound Oligosaccharides In Vivo
To understand in more detail the role of NLO in glycopro-
tein degradation, we determined the kinetics of protein-
bound oligosaccharide trimming in the ER in vivo. For
this, two yeast strains that carry the sec18-50 mutation
were used. The sec18-50 mutation results in a tempera-
ture-sensitive phenotype and prevents the fusion of ER-
derived vesicles with the Golgi apparatus at nonpermissive
temperature. No processing of protein-bound oligosaccha-
rides by Golgi glycosyltransferases was observed in sec18
mutant strains at nonpermissive conditions (Novick et al.,
1980; Eakle et al., 1988). We performed the experiments at
the permissive temperature for the sec18-50 mutation,
nevertheless, the export rate of secretory proteins to the
Golgi apparatus was slower in sec18-50 cells as compared
with wild-type cells and we were able to analyze the trim-
Figure 1. Biosynthesis and trimming of oligosaccharides in the
ER lumen of Saccharomyces cerevisiae. The lipid-linked oligosac-
charide precursors are synthesized at the ER membrane. Some of
the involved mannosyltransferases (encoded by the ALG3,
ALG9, and ALG12 loci) and their products as well as the gluco-
syltransferases (encoded by the ALG6, ALG8 and ALG10 loci)
and their respective products are depicted. The fully assembled
Glc3Man9GlcNAc2 oligosaccharide precursor is transferred to as-
paragine residues of the N-X-S/T sequence of polypeptides. This
is followed by trimming involving glucosidase I (GLS1), glucosi-
dase II (GLS2) and mannosidase I (MNS1) to yield the protein-
bound Man8GlcNAc2 oligosaccharide.The Journal of Cell Biology, Volume 142, 1998 1226
ming of the NLO in the ER. One of the strains carried in
addition a deletion in the GLS2 locus inactivating glucosi-
dase II. No growth phenotype was associated with the
Dgls2 mutation. Cells were labeled with 3H-mannose for 1
min at 268C and the radioactivity was chased by adding an
excess of nonradioactive (6)D-mannose. At the given
time points, the chase was terminated, NLO were released
from protein by endoglycosidase H (endo H), and then an-
alyzed by HPLC (see Materials and Methods section).
In the Dgls2 strain, only two trimming events occur in
the ER: the removal of the terminal a1,2-linked glucose
residue by glucosidase I and the cleavage of an a1,2-linked
mannose residue by mannosidase I. As expected, a pro-
tein-bound oligosaccharide with the putative structure
Glc2Man9GlcNAc2 (G2M9)2 was found, which was slowly
converted to Glc2Man8GlcNAc2 (G2M8) with a half-life of
z10 min (Fig. 2, A and B, left). We were unable to detect
protein-bound Glc3Man9GlcNAc2.
We analyzed the structure of the different oligosaccharides
in more detail. The endo H–released Glc2Man9GlcNAc2
NLO comigrated with the Glc2Man9GlcNAc2 oligosaccha-
2. Since the protein-bound oligosaccharides were released by Endo H
cleavage, they are lacking one GlcNAc residue. For clarity, however, the
NLO structure as found on protein is denoted.
Figure 2. In vivo kinetics of N-linked oligosaccharide trimming. Two
different yeast strains were used. Strain YG557 (Dgls2 sec18-50; left)
carries a deletion of the glucosidase II–encoding locus and a muta-
tion in the SEC18 locus resulting in a temperature-sensitive protein
transport from the ER to the Golgi compartment. Strain YG556
(sec18-50;  right) is fully competent in oligosaccharide trimming in the
ER. Cells were labeled with a 1-min pulse of 3H-mannose, followed
by a chase with an excess of unlabeled mannose. (A) Protein-bound
oligosaccharides were isolated at the time indicated after initiation of
the chase and analyzed by HPLC. The elution of radioactivity was
monitored. The proposed oligosaccharide structure is given for the
individual peaks. For explanation of the symbols, see Fig. 1. (B) Ki-
netics of maturation of N-linked oligosaccharides. The HPLC profiles shown in A were quantified using the FLO-ONE software (ver-
sion 3.6; Packard Instrument Co., Meriden, CT). The amount of radioactivity present in each individual peak was determined, expressed
as a percentage of total radioactivity present and plotted against time. The value for the G2M8 and the M8 oligosaccharide, respectively,
was corrected for the absence of one mannose residue. (C) Verification of NLO species by exo-a1,2-mannosidase digestion. The NLO
obtained from 5-min (sec18-50) and 10-min (Dgls2 sec18-50) chase periods (A) were treated with exo-a1,2-mannosidase from A. saitoi
and separated by HPLC. Endo H–treated LLO, obtained from a Dalg10 Dgls2 (G2) strain, was used as marker for the oligosaccharides.
The proposed oligosaccharide structure is given for the individual peaks. For explanation of the symbols, see Fig. 1. 2MNS, NLO with-
out exo-a1,2-mannosidase treatment; 1MNS, NLO after A. saitoi exo-a1,2-mannosidase cleavage.Jakob et al. Glycoprotein Degradation in Yeast 1227
ride obtained from endo H–treated LLO of a Dalg10 strain
(Fig. 2 C). This strain accumulates lipid-linked Glc2Man9
GlcNAc2 due to the inactivation of the a1,2 glucosyltrans-
ferase (Burda and Aebi, 1998). Digestion of the two major
protein-derived oligosaccharides from a Dgls2 sec18-50
strain by exo-a1,2-mannosidase (from Aspergillus saitoi)
converted both of them to a single species (Fig. 2 C).
Therefore, the two oligosaccharides found on protein in a
Dgls2 sec18 strain differed by one a1,2-linked mannose.
This observation, the mobility of the exo-a1,2-mannosi-
dase digestion product and the comigration of one oli-
gosaccharide with the Glc2Man9GlcNAc2 marker showed
that protein bound Glc2Man9GlcNAc2 and the corre-
sponding mannosidase product Glc2Man8GlcNAc2 were
present in the Dgls2 sec18-50 strain. The minor peak ob-
served after exo-a1,2-mannosidase digestion (Fig. 2 C,
left) was possibly due to incomplete digestion, since the
presence of glucose residues on oligosaccharides reduced
the efficiency of the enzyme (Burda, P., unpublished
data). Taken together, the results confirmed that release
of the a1,2-linked glucose from protein-bound oligosac-
charide by glucosidase I was a rapid process in the Dgls2
strain. However, trimming of the oligosaccharide by endo-
genous a1,2-mannosidase (Mns1p) occurred much slower.
When we analyzed the NLO processing in a strain fully
competent for trimming (sec18-50; Fig. 2, right), we were
again unable to detect the complete protein-bound Glc3
Man9GlcNAc2 oligosaccharide, even in preparations ob-
tained shortly after the pulse (Fig. 2, A and B, right). The
largest oligosaccharide, detected after 2 min of chase (1-
min pulse), comigrated with the Glc2Man9GlcNAc2 oli-
gosaccharide but represented a minor fraction (,10%) of
the total NLO. In contrast, significant amounts of Glc1
Man9GlcNAc2 were detected at this time point (the struc-
tural analysis of this oligosaccharide is described below).
However, from this oligosaccharide one or two hexose
units were rapidly trimmed. To determine whether this
trimming was due to glucosidase II or mannosidase I activ-
ity, we analyzed the NLO preparation from the 5-min
chase point by digestion with the exo-a1,2-mannosidase
(Fig. 2 C). This preparation contained small amounts of
oligosaccharides comigrating with the Glc1Man9GlcNAc2
standard and significant levels of oligosaccharides that mi-
grated as expected for Man9GlcNAc2 and Man8GlcNAc2
oligosaccharide. Indeed, digestion by exo-a1,2-mannosi-
dase revealed that only the Glc1Man9GlcNAc2 oligosac-
charides contained a protective glucose residue and was
converted to Glc1Man7GlcNAc2, whereas the majority of
the oligosaccharides was trimmed to Man5GlcNAc2. These
results showed that the Glc1Man9GlcNAc2 protein-bound
oligosaccharide was converted primarily to Man9GlcNAc2
and that the peak representing this oligosaccharide con-
tained no significant amounts of mannosidase I–trimmed,
monoglucosylated oligosaccharide.
The analysis of the structure of protein-bound oligosac-
charide species as well as their temporal appearance
showed that the removal of the terminal a1,2-glucose on
protein-bound oligosaccharides by glucosidase I was a
rapid process in vivo. Similarly, since we observed only
small amounts of diglucosylated oligosaccharides (Fig. 2,
A and B, 2-min chase), the hydrolysis of the first a1,3-
linked glucose by glucosidase II was a rapid process. We
concluded that under our experimental conditions, the
monoglucosylated oligosaccharide Glc1Man9GlcNAc2 was
converted to the Man9GlcNAc2 oligosaccharide with a
half-life of z2 min and that this occurred before process-
ing by mannosidase I, which was a relatively slow process
(half-life 10 min). Evidently, removal of glucose-linked
residues was not a prerequisite for mannosidase I action
because mannose hydrolysis occurred with approximately
the same kinetics in both glucosidase II–proficient or –defi-
cient strains (Fig. 2 B).
Role of N-linked Oligosaccharides in
Glycoprotein Processing
Removal of a mannose residue by a1,2-mannosidase con-
cludes the trimming of NLO in the ER of S. cerevisiae
(Byrd et al., 1982). Since this cleavage occurred at a slow
rate, we speculated that it represents a rate-limiting step
and thus is important for efficient glycoprotein transport
and maturation. Therefore, we analyzed this aspect in de-
tail by studying the processing of vacuolar proteinase
CPY. In the ER, CPY receives four N-linked oligosaccha-
rides (p1CPY, glycosylated proCPY, 67 kD) that are mod-
ified in the Golgi apparatus (p2CPY, 69 kD). Upon reach-
ing the vacuole, CPY maturates by proteolytic cleavage of
the propeptide (mCPY, 63 kD). In a pulse–chase experi-
ment, we compared the transport rates of CPY, from ER
to Golgi and to vacuole in wild-type and Dmns1 strains
lacking a1,2-mannosidase activity. We observed that CPY
was transported at the same rates (Fig. 3). This demon-
strated that trimming of NLO by mannosidase I was not
required for export of glycosylated CPY to the Golgi ap-
paratus and the transport to the vacuole.
Role of N-linked Oligosaccharides in Degradation of 
Misfolded CPY
Previous studies have shown that a specifically mutated
form of vacuolar proteinase CPY (CPY*) is retained in
the ER and degraded by the proteasome (Hiller et al.,
1996) in an oligosaccharide-dependent manner (Knop et al.,
1996). Moreover, deletion of the MNS1 locus affects the
degradation of CPY*. These observations suggested that
trimming of the oligosaccharides is required for processing
Figure 3. Maturation of CPY in wild-type and mannosidase-defi-
cient mutant cells. Logarithmically growing cells were pulsed
with  35S-methionine for 5 min at 268C and then chased for 30 min.
The cells were broken, CPY immunoprecipitated, separated by
SDS-PAGE and visualized by autoradiography. The processing
of CPY in wild-type cells (wt, strain SS328) is shown in the top
panel, that of mannosidase-deficient cells (mns1, strain YG746)
in the bottom panel. The positions of the ER-modified form of
proCPY (p1CPY); of the Golgi-modified form of proCPY
(p2CPY) and of the vacuolar mature CPY (mCPY) are indicated.The Journal of Cell Biology, Volume 142, 1998 1228
of misfolded CPY in the ER. To precisely define the NLO
moieties important for proteasome-dependent degrada-
tion of CPY*, we generated yeast strains containing CPY*
carrying defined NLO structures on glycoproteins (for de-
tails, see Fig. 1 and Table III).
In a first step, we investigated the influence of glucose
residues of oligosaccharides on CPY* degradation (Fig. 4).
For that purpose, we constructed mutant strains that pro-
duced the following NLO structures: Glc2Man8GlcNAc2
(G2; Dalg10 Dgls2), Glc1Man8GlcNAc2 (G1; Dalg8 Dgls2),
Man8GlcNAc2 (G0; wild-type and Dalg6 Dgls2). It is im-
portant to note that a1,2-mannosidase can act on glucosy-
lated oligosaccharides in vivo (Fig. 2). When we analyzed
the processing of CPY* by pulse–chase experiments, a dif-
ferential degradation of CPY* was observed depending on
the number of glucose residues present on the NLO (Fig.
4). The G2 CPY* (Dalg10 Dgls2) was degraded at the slow-
est rate, whereas the G0 CPY* was degraded at the same
rate as CPY* in a strain with normal oligosaccharide bio-
synthesis and trimming (Fig. 4, wild-type). By Western
blot analysis, another G2 CPY*, Dgls2, behaved similarly
as G2 CPY* (Dalg10 Dgls2, see below and Fig. 5 C). For
the G1 CPY*, we observed an intermediate degradation
rate (Fig. 4). From the initial degradation rates (time
points 30 and 60 min), we calculated the half-life of CPY*
in the various strains (Table IV). In the wild-type and the
G0 cells it was 21 min, similar to published data (Hiller et
al., 1996). In comparison, the half-life of CPY* in the G1
cells was 43 min and in the G2 cells 82 min under our ex-
perimental conditions. Thus, the larger the number of glu-
cose residues the NLO of CPY* contained, the slower its
degradation rate.
Next, we determined whether mannose residues of the
NLO influenced degradation of CPY*. The core mannose
structure of LLO is synthesized by a set of sequentially
acting ER mannosyltransferases (Alg3p, Alg9p, Alg12p;
see Fig. 1, Orlean, 1997). Due to the fact that incompletely
assembled oligosaccharides can be transferred to protein,
albeit with a reduced efficiency, we were able to obtain
yeast strains with incomplete, but defined NLO structures,
namely Man5GlcNAc2 (M5, Dalg3; Aebi et al., 1996),
Man6GlcNAc2 (M6, Dalg9; Burda et al., 1996), Man7
GlcNAc2 (M7, Dalg12, Burda and Aebi, manuscript in
preparation), Man8GlcNAc2 (M8, wild-type with respect
to NLO; M8, Dalg6; Reiss et al., 1996), and Man9GlcNAc2
(M9, Dmns1; Puccia et al., 1993; see also Table III).
When the half-lives of mutant CPY* bearing various oli-
gosaccharide structures were analyzed, we found that
CPY* containing Man8GlcNAc2 NLO was rapidly de-
Table III. Structure of N-linked Oligosaccharides in Mutant Yeast Strains
Genotype NLO after transfer Final NLO structure* Underglycosylation References
Dgls2 Glc3Man9GlcNAc2 Glc2Man8GlcNAc2 (G2) No This study
Dalg10 Dgls2 Glc2Man9GlcNAc2 Glc2Man8GlcNAc2 (G2) Yes Jakob et al. (1998)
Dalg8 Dgls2 Glc1Man9GlcNAc2 Glc1Man8GlcNAc2 (G1) Yes Jakob et al. (1998)
Dalg6 Dgls2 Man9GlcNAc2 Man8GlcNAc2 (G0) Yes Jakob et al. (1998)
Dmns1 Glc3Man9GlcNAc2 Man9GlcNAc2 (M9) No Puccia et al. (1993)
Wild-type‡ Glc3Man9GlcNAc2 Man8GlcNAc2 (M8) No Jakob et al. (1998), Verostek et al. (1991, 1993),
Ziegler and Trimble (1991)
Dalg6 Man9GlcNAc2 Man8GlcNAc2 (M8) Yes Reiss et al. (1996)
Dalg12 Man7GlcNAc2 Man7GlcNAc2 (M7) Yes Burda, P., C.A. Jakob, J. Beinhauer, J.H.
Hegemann, and M. Aebi, manuscript submitted for publication
Dalg9 Man6GlcNAc2 Man6GlcNAc2 (M6) Yes Burda et al. (1996)
Dalg3 Man5GlcNAc2 Man5GlcNAc2 (M5) Yes Aebi et al. (1996)
*Oligosaccharide structure on glycoproteins (NLO) after endogenous glycosidase trimming. The term in parenthesis indicates the abbreviations used throughout the figures.
‡The term wild-type is used with regard to oligosaccharide biosynthesis and trimming.
Figure 4. Degradation of misfolded CPY with glucosylated oli-
gosaccharides. (A) Cells were labeled with a short pulse with
35S-labeled methionine, chased with an excess of unlabeled me-
thionine, lyzed at the time indicated after the chase and CPY*
was precipitated using CPY-specific antiserum. Precipitated
CPY* was resolved by SDS-PAGE, autoradiography was per-
formed using a PhosphoImager System and the level of CPY*
was determined. The CPY* level at initiation of the chase was
taken as 100%. Degradation rates of misfolded CPY were calcu-
lated from two independent experiments. (B) Autoradiography
of immunoprecipitated misfolded CPY resolved by SDS-PAGE.
The time of the chase is indicated above the lanes. The following
strains indicated on the left side of A and above the different au-
toradiographs (B) were used in the analysis: wt: prc1-1, YG618;
G0: Dalg6 Dgls2 prc1-1, YG623; G1: Dalg8 Dgls2 prc1-1, YG624;
G2: Dalg10 Dgls2 prc1-1, YG625.Jakob et al. Glycoprotein Degradation in Yeast 1229
graded (Fig. 5 A, lanes 1 and 6 and B). The Man5GlcNAc2
CPY* (Fig. 5, A lane 2 and B) was degraded at a reduced
rate compared with the Man8GlcNAc2 CPY*. However, a
greatly reduced rate of CPY* degradation was observed
when the NLO were of Man6GlcNAc2 (Fig. 5 A, lane 3 and
B), Man7GlcNAc2 (Fig. 5 A, lane 4 and B), and Man9
GlcNAc2 (Fig. 5 A, lane 5 and B) structures. By Western
blot analysis, CPY* with diglucosylated oligosaccharides
(Dgls2) was also degraded at a slower rate than Man8
GlcNAc2 CPY* (Fig. 5 C, compare with Fig. 4). However,
the stabilization was not as prominent as for Man9
GlcNAc2 CPY* (Dmns1; Fig. 5 C). Taken together, our re-
sults showed that efficient degradation of CPY* was de-
pendent on the NLO structure. Man8GlcNAc2 CPY* was
rapidly degraded, whereas the trimming intermediate
Man9GlcNAc2 CPY* and the incompletely assembled
Man6-7GlcNAc2 CPY* were inefficiently degraded.
To demonstrate that the differences in degradation rate
of CPY* were due to the altered oligosaccharide structure,
we transformed the yeast cells with plasmids complement-
ing the deleted gene loci. The Dalg3, Dalg9, and Dalg12
cells were transformed with plasmids containing the
ALG3 (pALG3), ALG9 (pALG9) and ALG12 (pALG12)
locus. Further, the CPY* wild-type strain was transformed
with the vector plasmid (YEp352). The NLO structure-
dependent CPY* degradation phenotype could be re-
verted by complementing the deleted alg gene loci with
the appropriate plasmids (Fig. 5 D, lanes 3–8), but the deg-
radation in wild-type cells was not influenced by the trans-
formation with the empty plasmid (Fig. 5 D, lanes 1 and 2).
Incomplete assembly of the LLO leads to a reduced oli-
gosaccharide transfer to protein by the oligosaccharyl-
transferase (Sharma et al., 1981; Silberstein and Gilmore,
1996), which is then apparent by underglycosylation of gly-
coproteins (Huffaker and Robbins, 1981, 1983; Stagljar et al.,
1994; te Heesen et al., 1994; Burda et al., 1996; Burda and
Aebi, 1998). The equal degradation of Man8GlcNAc2
CPY* in glycosylation wild-type cells and in Dalg6 cells
(Fig. 5 A, lanes 1 and 6) indicated that the degradation was
not due to impaired synthesis of LLO, but rather to the al-
tered oligosaccharide structure.
Also, in contrast to wild-type CPY, CPY* was efficiently
glycosylated in both Dalg3 (Man5GlcNAc2) and Dalg9
(Man6GlcNAc2) cells under the conditions used. We ob-
served a single CPY* glycoform in Dalg3 prc1-1 and Dalg9
prc1-1 cells (Fig. 6, lanes 1 and 3), whereas correctly folded
CPY was incompletely glycosylated in Dalg3 and Dalg9
cells (Fig. 6, lanes 7 and 9). This hypoglycosylation of CPY
was visualized by the distinct bands upon Western blot
analysis representing different glycoforms of this protein
(Stagljar et al., 1994). In addition, this experiment showed
that such forms of CPY* did not reach the vacuole be-
cause endo H treatment resulted in the deglycosylated
pro-form of CPY* in Dalg9 cells (Fig. 6, lanes 3 and 4,
compare with lanes 9 and 10). As expected, the oligosac-
charides in Dalg3 cells were resistant to endo H digestion,
Figure 5. N-linked oligosaccharide structure affects degradation
of misfolded CPY. Yeast cells were grown into stationary phase
(A and C, cells grown in YPD; D, growth in minimal medium),
equal cell numbers harvested and their proteins were extracted,
separated by SDS-PAGE, transferred to nitrocellulose and
probed with antiserum for CPY. The membranes were stripped
and reprobed with antiserum directed against hexokinase (HXK)
which served as internal standard. All strains analyzed in this fig-
ure contained the prc1-1 mutation. The relevant genotype of the
strains analyzed is given above each lane or below each column,
respectively. Strains: YG618 (wt, wild-type, lanes A1, C1, and
D1); YG797 (Dalg3, lanes A2 and D3); YG796 (Dalg9, lanes A3
and D5); YG807 (Dalg12, lanes A4 and D7); YG777 (Dmns1,
lanes A5 and C3); YG620 (Dalg6, lane A6); YG619 (Dgls2, lane
C2); YG821 (wild-type 1 YEp352, lane D2); YG822 (Dalg3 1
pALG3, lane D4); YG823 (Dalg9 1 pALG9, lane D6); YG824
(Dalg12  1 pALG12, lane D8); Abbreviations: wt, wild-type;
CPY*, misfolded CPY; HXK, hexokinase. (A) Degradation of
misfolded CPY is dependent on core mannose residues. The posi-
tion of malfolded CPY* is indicated. The mobility of CPY* in
SDS-PAGE varied due to the different oligosaccharide struc-
tures. (B) Quantification of degradation of misfolded CPY. Pro-
tein amounts (mean 6 SD) of three independent Western blot
experiments as shown in A were quantified by using a CCD cam-
era and the Wincam V2.1 software (Cybertech, Berlin, Germany)
and normalized to the hexokinase levels. The amount of mis-
folded CPY of the wild-type strain was set as 1.0. (C) Degrada-
tion of misfolded CPY is reduced in Dgls2 and Dmns1 cells but
not in wild-type cells. The mobility of CPY* in SDS-PAGE var-
ied due to the different oligosaccharide structures. (D) Degrada-
tion of CPY* is dependent on the altered oligosaccharide struc-
tures. Wild-type and mutant strains with altered oligosaccharide
biosynthesis (indicated above the lanes) with (1) or without (2)
the corresponding complementing plasmid were analyzed for
degradation of CPY* by Western blot analysis. The position of
CPY* is indicated. Hexokinase served as a control protein.
Table IV. Calculated Half-life of Mutated CPY
Genotype of strains Half-life*
prc1-1 (wild-type) 20.8 6 3.7
Dalg6 Dgls2 prc1-1 (G0) 21.9 6 1.0
Dalg8 Dgls2 prc1-1 (G1) 43.3 6 0.3
Dalg10 Dgls2 prc1-1 (G2) 82.3 6 1.1
*The values (mean 6 SD) represent the calculated half-lives from time points 0, 30,
and 60 min and were derived from the experiment shown in Fig. 2.The Journal of Cell Biology, Volume 142, 1998 1230
whereas in Dalg9 cells they were endo H sensitive (Fig. 6,
lanes 8 and 10).
In Dalg3 or Dalg9 cells, a much higher steady state level
of CPY was observed compared with CPY* in various mu-
tant cells (Fig. 6). This indicated that degradation of CPY*
was not completely blocked by the altered oligosaccharide
structure. However, our results demonstrated that oli-
gosaccharide structures specifically affected the degrada-
tion of misfolded CPY accumulating in the ER, whereas
processing and secretion of wild-type CPY was not al-
tered.
Discussion
A Defined Oligosaccharide Structure Was Required for 
Efficient Degradation of Misfolded Glycoprotein
We observed a significant effect of the structure of N-linked
oligosaccharides on degradation of misfolded CPY*, a
model protein for degradation of glycoproteins retained in
the ER (Wolf and Fink, 1975; Finger et al., 1993; Hiller et
al., 1996; Knop et al., 1996). When expressed in Dgls2 or
Dmns1 cells, we found a reduced degradation of CPY*
(Fig. 5 C). The effect of the mannosidase I inactivation
was significantly stronger than that of the glucosidase II
deletion. A similar stabilization of CPY* as in Dmns1 cells
was observed in Dalg9 and Dalg12 cells, where incom-
pletely mannosylated oligosaccharides (Man6GlcNAc2 and
Man7GlcNAc2, respectively) were transferred to protein.
In  Dalg3 cells, which contain protein-bound Man5Glc
NAc2, degradation of CPY* was reduced, however, not to
the same extent as in Dalg9 or Dalg12 cells. Interestingly,
in  Dalg6 cells, where nonglucosylated oligosaccharide
Man9GlcNAc2 was transferred to protein and trimmed
to Man8GlcNAc2, no effect on the stabilization of CPY*
was observed. We concluded, that the protein-bound
Man8GlcNAc2 structure was an important recognition ele-
ment in the degradation pathway of CPY*. Our results
were best explained by a model (Fig. 7) where the
Man8GlcNAc2 oligosaccharide on a misfolded glycopro-
tein acted as a positive signal for degradation. This oli-
gosaccharide structure might be recognized by a lectin,
since any changes in its structure reduced the efficiency of
degradation. Such a carbohydrate-binding protein has also
been postulated in the degradation of glycoproteins in
mammalian cells (Yang et al., 1998) and might represent
“the additional signal to direct them (soluble misfolded
proteins) to the dislocation and the ubiquitation machin-
ery” (Kopito, 1997). Our results showed that glucosylated
oligosaccharides also reduced the degradation rate of
CPY*, albeit to a lesser extent than the Man9GlcNAc2,
Man7GlcNAc2 and Man6GlcNAc2 structures. We con-
cluded that the a1,2-a1,2-dimannose branch of the Man8
GlcNAc2 oligosaccharide was a less important structural
element for oligosaccharide recognition than both the
a1,6- and a1,3-branch affected by the alg3, alg9 and alg12
mutations (see Fig. 1). The observation that the Man5
GlcNAc2-producing Dalg3 mutation had a less severe ef-
fect on degradation was explained by the hypothesis that
this oligosaccharide structure represents an intermediate
Figure 6. Processing of wild-type CPY occurs independent of
NLO structure. Yeast cells were grown into stationary phase,
equal cell numbers harvested and their proteins extracted. Ex-
tracts were analyzed before (2) or after endo H (1) treatment.
The proteins were separated by SDS-PAGE, transferred to nitro-
cellulose and probed with antiserum to detect CPY. After expo-
sure, membranes were stripped and reprobed with antiserum di-
rected against hexokinase (HXK). Dalg3 strains (lanes 1, 2, 7, and
8) and Dalg9 strains (lanes 3, 4, 9, and 10) carrying a mutant prc1-1
locus expressing CPY* (lanes 1–4) or a wild-type PRC1 locus
(lanes 5–10) were analyzed. The positions of the ER form
p1CPY* and deglycosylated proCPY* (dpCPY*) are shown at
the left (lanes 1–4). Mature, wild-type CPY (mCPY), lacking one
(21) or two (22) oligosaccharides and deglycosylated, mature
CPY (dCPY) are indicated on the right side (lanes 5–10). The fol-
lowing strains were used: YG797 (Dalg3 prc1-1), YG796 (Dalg9
prc1-1), SS328 (PRC1), YG228 (Dalg3 PRC1), and YG414 (Dalg9
PRC1).
Figure 7. A role of N-linked oligosaccharides in the degradation
of glycoproteins in yeast. A secreted glycoprotein folds in the lu-
men of the ER with the help of chaperone(s). The N-linked oli-
gosaccharide of the glycoprotein is trimmed by glycosidases (indi-
cated by the three arrows) to the Man8GlcNAc2 structure. The
correctly folded protein is exported to the Golgi compartment. If
folding of the glycoprotein is not completed within the time re-
quired for complete oligosaccharide trimming, the misfolded gly-
coprotein, bearing oligosaccharides of the Man8GlcNAc2 struc-
ture and associated with chaperone(s), is targeted for export to
the cytosol, where degradation by the proteasome occurs. A lec-
tin, recognizing specifically the Man8GlcNAc2 structure, is in-
volved in the targeting of the malfolded protein to the degrada-
tion pathway.Jakob et al. Glycoprotein Degradation in Yeast 1231
in the degradation of glycoprotein as shown in higher eu-
karyotic cells (Villers et al., 1994; Ermonval et al., 1997).
Whether the postulated lectin additionally recognizes
unfolded protein domains, as does UDP-glucose/glycopro-
tein glucosyltransferase, involved in the ER quality con-
trol pathway of higher eukaryotes (Sousa and Parodi,
1995), is not known. It is possible that the binding of both,
the chaperones and the postulated lectin constitute a sig-
nal which targets the glycoprotein to the degradation path-
way. Indeed Kar2p, the yeast homologue of BiP, tran-
siently binds to wild-type CPY (te Heesen and Aebi, 1994;
Simons et al., 1995). Furthermore, this Hsp70 protein was
shown to be involved in the degradation of misfolded pro-
tein by the proteasome pathway (Plemper et al., 1997).
It has been proposed that the trimming of the protein-
bound oligosaccharide in the endoplasmic reticulum rep-
resents a biological timer for the protein maturation in the
ER of higher eukaryotes (Helenius et al., 1997). This timer
function might be required to prevent permanent resi-
dence of misfolded glycoproteins in the ER due to the
binding to calnexin and calreticulin in higher eukaryotes.
Our results are fully compatible with this timer model: as
in higher eukaryotic cells (Hubbard and Robbins, 1979),
the protein bound oligosaccharide underwent a step-wise
trimming process. Removal of the terminal a1,2-glucose
by glucosidase I and the first a1,3-glucose by glucosidase
II was a very rapid process, whereas the second a1,3-glu-
cose was removed more slowly. The same difference in
glucose hydrolysis was observed for glucosidase II of
higher eukaryotic cells (Hubbard and Robbins, 1979) and
it has been proposed that two different substrate binding
sites of glucosidase II are responsible for this difference:
the high affinity site would be responsible for the hydroly-
sis of the first glucose, the low affinity site for the hydroly-
sis of the second glucose (Alonso et al., 1993). Similar to
the findings in higher eukaryotic cells, the mannose trim-
ming was a slow process as compared with hydrolysis of
the glucose residues of the protein-bound oligosaccharide.
The removal of one specific a1,2-mannose residue by ER-
a1,2-mannosidase might represent the time-point after
which a misfolded protein is routed to the degradation
pathway. We speculated that the processing by mannosi-
dase I determined the time-scale in which a protein had to
be correctly folded. If this was not achieved, the glycopro-
tein was degraded. Importantly, maturation and transport
of correctly folded CPY is oligosaccharide-independent
(Schwaiger et al., 1982; Winther et al., 1991) and was also
not influenced by trimming or oligosaccharide structure
(Figs. 3 and 6). It was also postulated that there is a selec-
tive export of proteins out of the ER in yeast (Kuehn and
Schekman, 1997). Selective export of only correctly folded
proteins in combination with degradation of misfolded
proteins, timed by oligosaccharide trimming, might there-
fore represent an effective quality control system for gly-
coprotein folding in the ER of S. cerevisiae, where the
calnexin/calreticulin cycle (reglucosylation of misfolded
proteins) has not been found (Fernandez et al., 1994, Ja-
kob et al., 1998).
In support of our model, we found that the degradation
of a mutant form of the oligosaccharyltransferase compo-
nent Stt3p, a glycoprotein with multiple transmembrane
domains (Zufferey et al., 1995) was also controlled by oli-
gosaccharide trimming (Bodmer, D., U. Spirig, and M.
Aebi, manuscript in preparation), suggesting that resident
ER glycoproteins are subject to the same degradation sys-
tem as are glycoproteins that are exported from the ER.
Is there a similar role of the Man8GlcNAc2 oligosaccha-
ride in the quality control process of glycoproteins in the
ER of higher eukaryotic cells? In the trimming process of
protein-bound oligosaccharides, removal of the glucose
residues precedes the hydrolysis mannose trimming (Hub-
bard and Robbins, 1979). There is an a1,2-mannosidase
activity that leads to the same Man8GlcNAc2 oligosaccha-
ride as the yeast MNS1 enzyme in the ER of higher eu-
karyotic cells (Bischoff and Kornfeld, 1983). However,
there are additional ER mannosidase activities in the ER
of higher eukaryotic cells and a different Man8GlcNAc2
oligosaccharide isomer, where the a1,2-mannose linked to
the a1,6-mannose is removed, can be produced (Weng and
Spiro, 1993, 1996; Moremen et al., 1994). The trimming
process in higher eukaryotes is therefore more complex
than in yeast. Nevertheless, our results obtained in yeast
are compatible with reports on inhibition of a-mannosi-
dase trimming by deoxymannojirimycin that stabilizes spe-
cific misfolded glycoproteins in the ER (Su et al., 1993;
Daniel et al., 1994; Liu et al., 1997; Yang et al., 1998). On
the other hand, degradation of some glycoproteins in the
ER was not affected by mannosidase inhibition (Yang et al.,
1998).
Alternative Pathways for ER Degradation?
Previous work has shown that CPY* remains in the ER, is
ubiquitinated and then degraded in a proteasome-depen-
dent pathway (Hiller et al., 1996). When we compared the
level of wild-type CPY and mutant CPY* in both the
Dalg9 and Dmns1 cells (Figs. 5 A and 6), it was apparent
that more mature (vacuolar) CPY was present in wild-type
cells than CPY* in the prc1-1 cells. A major portion of
CPY* was apparently degraded in these cells. Our results
showed that alterations of the oligosaccharide structure
did not completely block degradation of CPY*. Moreover,
mutations reported to affect CPY* degradation do not
completely block CPY* degradation either (Hiller et al.,
1996; Knop et al., 1996; Plemper et al., 1997). Taken to-
gether, these results suggest an alternative, glycosylation-
independent degradation pathway for misfolded glycopro-
teins in the ER of S. cerevisiae.
Evidence for Posttranslocational N-Glycosylation
of CPY*
N-linked oligosaccharides are added co- and posttranslo-
cationally in yeast. For CPY, competition between glyco-
sylation and folding has been reported (Holst et al., 1996).
In cells containing alg mutations, incompletely assembled
oligosaccharide is transferred to nascent protein (Stagljar
et al., 1994), albeit at a reduced rate (Sharma et al., 1981).
This is reflected by incomplete use of potential N-glyco-
sylation sites. However, we noticed that in both Dalg3 and
Dalg9 cells, only CPY* with all four potential N-glycosyla-
tion sites occupied accumulated, whereas in the Dalg3 and
Dalg9 cells, wild-type CPY lacking one or two oligosaccha-
rides were found (Fig. 6). Therefore, we postulated that
the prolonged exposure of misfolded CPY* to the oli-The Journal of Cell Biology, Volume 142, 1998 1232
gosaccharyltransferase compensated for the reduced affin-
ity of the oligosaccharyltransferase towards incompletely
assembled oligosaccharide and resulted in fully glycosy-
lated CPY* in both Dalg3 and Dalg9 cells.
The assembly of the lipid-linked oligosaccharide and its
transfer to selected asparagine residues of polypeptides in
the ER is a highly conserved process. The selective pro-
cessing of the protein-bound oligosaccharide supports the
idea that conservation of the transferred oligosaccharide
structure is due to the function of specific trimming inter-
mediates in glycoprotein maturation. Genetic tailoring of
NLO structures will provide a useful tool to identify ad-
ditional roles of the oligosaccharide in glycoprotein pro-
cessing.
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